NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling

被引:84
|
作者
Ohtsuka, M
Arase, H
Takeuchi, A
Yamasaki, S
Shiina, R
Suenaga, T
Sakurai, D
Yokosuka, T
Arase, N
Iwashima, M
Kitamura, T
Moriya, H
Saito, T [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Orthoped, Chiba 2608670, Japan
[3] Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan
[4] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan
[5] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[6] Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1088639, Japan
关键词
D O I
10.1073/pnas.0401119101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A functional cDNA cloning system was developed by using a retrovirus library encoding CD8-chimeric proteins and a nuclear factor of activated T cells (NFAT)-GFP reporter cell line to identify molecules inducing NFAT activation. By using this strategy, NFAT activating molecule 1 (NFAM1) was cloned as an immunoreceptor tyrosine-based activation motif (ITAM)-bearing cell surface molecule belonging to the Ig superfamily and is predominantly expressed in spleen B and T cells. NFAM1 crosslinking induced ITAM phosphorylation, ZAP-70/Syk recruitment, NFAT activation, and cytokine production. In vivo overexpression of NFAM1 in bone marrow chimeras and transgenic mice induced severe impairment of early B cell development in an ITAM-dependent manner. in NFAM1-expressing B cells, B cell antigen receptor stimulation induced NFAM1 translocation to lipid raft, and NFAM1 co-crosslinking augmented B cell antigen receptor signaling. The results suggest that NFAM1 modulates B cell signaling through its ITAM, which regulates B cell development.
引用
收藏
页码:8126 / 8131
页数:6
相关论文
共 50 条
  • [41] Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs
    Mocsai, Attila
    Abram, Clare L.
    Jakus, Zoltan
    Hu, Yongmei
    Lanier, Lewis L.
    Lowell, Clifford A.
    NATURE IMMUNOLOGY, 2006, 7 (12) : 1326 - 1333
  • [42] The FcεRIβ immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IκB kinase phosphorylation and mast cell cytokine production
    Furumoto, Y
    Nunomura, S
    Terada, T
    Rivera, J
    Ra, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 49177 - 49187
  • [43] Platelet Immunoreceptor Tyrosine- Based Activation Motif ( ITAM) Signaling and Vascular Integrity
    Boulaftali, Yacine
    Hess, Paul R.
    Kahn, Mark L.
    Bergmeier, Wolfgang
    CIRCULATION RESEARCH, 2014, 114 (07) : 1174 - 1184
  • [44] Neuroprotective function of the microglial immunoreceptor tyrosine-based inhibitory motif-signaling receptor Siglec-11
    Yiner, Wang
    Janine, Claude
    Bettina, Linnartz
    Harald, Neumann
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 168 - 168
  • [45] Analysis of immunoreceptor tyrosine-based activation motif (ITAM) binding to ZAP-70 by surface plasmon resonance
    Vely, F
    Nunes, JA
    Malissen, B
    Hedgecock, CJR
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) : 3010 - 3014
  • [46] Downstream signaling molecules bind to different phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) peptides of the high affinity IgE receptor.
    Kimura, T
    Kihara, H
    Bhattacharyya, S
    Sakamoto, H
    Appella, E
    Siraganian, RP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1781 - 1781
  • [47] IMMUNOGLOBULIN G FC RECEPTORS WITH AN IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF PROMOTES DIABETIC NEPHROPATHY IN THE EARLY STAGE
    Liu, Fei
    Li, Jun
    Cai, Panpan
    Su, Xiaofeng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [48] Growth Factor Receptor-Bound Protein 2 Contributes to ( Hem) Immunoreceptor Tyrosine-Based Activation Motif-Mediated Signaling in Platelets
    Duetting, Sebastian
    Voegtle, Timo
    Morowski, Martina
    Schiessl, Sarah
    Schaefer, Carmen M.
    Watson, Stephanie K.
    Hughes, Craig E.
    Ackermann, Jochen A.
    Radtke, Daniel
    Hermanns, Heike M.
    Watson, Steve P.
    Nitschke, Lars
    Nieswandt, Bernhard
    CIRCULATION RESEARCH, 2014, 114 (03) : 444 - 453
  • [49] The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear
    Loren, Cassandra P.
    Aslan, Joseph E.
    Rigg, Rachel A.
    Nowak, Marie S.
    Healy, Laura D.
    Gruber, Andras
    Druker, Brian J.
    McCarty, Owen J. T.
    THROMBOSIS RESEARCH, 2015, 135 (01) : 155 - 160
  • [50] CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif
    Gary-Gouy, H
    Harriague, J
    Dalloul, A
    Donnadieu, E
    Bismuth, G
    JOURNAL OF IMMUNOLOGY, 2002, 168 (01): : 232 - 239